Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution

scientific article published on 01 November 1999

Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S005200050304
P698PubMed publication ID10541986

P2093author name stringNovotny J
West D
Sufliarsky J
Trupl J
Krcmery V Jr
Kunova A
Jurga L
Mardiak J
Mateicka F
Mrazova M
Sabo A
Grey E
Sorkovska D
Sevcikova L
P433issue6
P921main subjectcandidemiaQ54946225
Candida albicansQ310443
P304page(s)428-431
P577publication date1999-11-01
P1433published inSupportive Care in CancerQ15766919
P1476titleNosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution
P478volume7

Reverse relations

cites work (P2860)
Q42682766An Update on Candida tropicalis Based on Basic and Clinical Approaches
Q31058690Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins
Q37580801Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Q37450019Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis
Q34521837Candidaemia and cancer: patients are not all the same
Q30799502Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces
Q44375010Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit
Q35599856Glucocorticoids and invasive fungal infections
Q40627835Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades
Q45144414Is there in vivo-in vitro correlation between antifungal susceptibility, species of Candida spp. and clinical outcome?
Q33195001Oral and intestinal mucositis — causes and possible treatments

Search more.